SINGAPORE - A drug, which aims to improve survival chances of relapsed myeloma patients, has been approved by the Health Sciences Authority (HSA).
Myeloma is an incurable blood cancer in the bone marrow or soft tissue. Symptoms include bone pain, kidney failure, and anaemia.
TO READ THE FULL ARTICLE
Thank you for reading The Straits Times
You have reached one of our Premium stories. To continue reading, get access now or log in if you are a subscriber.
What is Premium?